G2 checkpoint control: checking in to the last resort for DNA damage.
Jackson
Jeffrey R
JR
Department of Molecular and Cellular Oncology, GlaxoSmithKline, Collegeville, Pennsylvania, USA. jeffrey.r.jackson@gsk.com
Zhou
Bin-Bing
BB
D004249:DNA Damage; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000096:biosynthesis / Q000494:pharmacology; D015536:Down-Regulation; D016195:G2 Phase; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology / Q000628:therapy
D004268:DNA-Binding Proteins